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Abstract
Reactive oxygen species modulate the cell growth of a
wide variety of mammalian cells. To determine whether
oxidative metabolism is altered during the
differentiation process, we studied the expression of
pro- and antioxidant proteins in proliferating and
differentiated CaCo-2 cells, a human colon
adenocarcinoma cell line. Nitric oxide synthase type 2
(INOS) produces nitric oxide (NO). Depending on its
rate of synthesis, NO may either promote cellular and
DNA damage or reduce the ability of other free radicals
to induce cell injury. Using Western and Northern
blot analysis and arginine conversion assay, we
demonstrate that the expression of iNOS decreases
when cells undergo differentiation. This biological event
entails a diminished producon of NO metabolites and
correlates with the loss of activation of soluble guanylate
cyclase activity. In differentiated cells, a 2-fold down-
regulation of the nuclear factor scB activity was observed,
suggesting that nuclear factor scB could be one of the
1NOS gene regulatory factors in the CaCo-2 model. In
parallel, we studied the expression of other antioxidant
proteins including glutathione S-transferase a (GSTa),
bcl-2, and the metallOthiOneinS (MTs). We show that the
protein levels of GSTa and MT increase du#{241}ngthe
differentiation of CaCo-2 cells, whereas bcl-2 levels
decrease. Our investigation indicates that the expression
of iNOS, GSTa, bcl-2, and MT is associated with the
enterocytic differentiation. The shift in the expression of
specific antioxidant genes du#{241}ngCaCo-2 cell
differentiation may occur to avoid alterations in the cell
redox potential
Introduction
Free radicals are involved in the control of cell growth and
differentiation. At physiological levels, they promote mito-
genic responses in several mammalian cell types (1),
whereas at higher concentrations, they induce cell damage
and apoptosis (2). Furthermore, the constitutive production
of H202 (3), superoxide (02), and hydroxyl radical (-OH; Ref.
4) in several human tumor cell lines suggests that oxidative
stress may play a role in cell dedifferentiation. Altogether,
these observations support the notion that the balance be-
tween radical production and antioxidant defenses may be a
determinant in cell growth, apoptosis, and differentiation.
NO3 is a pleiotropic messenger (5) involved in endotheli-
um-dependent vascular relaxation, neuromodulation, inhibi-
tion of platelet aggregation, immunological reactions (6), and
iron homeostasis (7). It is produced by the metabolism of
L-arginine, which is catalyzed by a family of enzymes, the
nitric oxide synthases (8). iNOS, the inducible isoform, the
expression of which is cytokine dependent, has been de-
tected in normal enterocytes (9), but its function in this epi-
thelium is not known. A higher level of iNOS activity has been
found in human colon cancers as compared to peritumoral
tissues,4 and the fact that this enzyme is constitutively ex-
pressed in several human colon adenocarcinoma cell lines
(1 0, 1 1) suggests that it has a role in the dedifferentiation of
colon cells. NO may disturb cell growth by regulating the
activity of cellular targets involved in signal transduction, Al?
and oxygen production, and iron sequestration. Indeed, NO
activates the sGC (5), inhibits (iron-cluster) enzymes includ-
ing aconitase and mitochondrial complex I and II enzymes
(6), and enhances the DNA binding of transcription factors
connected to the iron homeostasis (7). Its dual chemical
properties as a pro- or antioxidant compound (12-1 6) may
also account for a role of NO in the modulation of cell
proliferation via its effects on cell redox potential. NO has the
potential to reduce the intracellular level of H202, because it
inhibits the NADPH oxidase (14) and interacts with the su-
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Fig. 1 . Enzymatic and structural features of CaCo-2 cell differentiation.
A, Western blot analysis of villin expression. Fifty-jig cell extracts of
proliferating (1) or differentiated (2) CaCo-2 cells were subjected to elec-
trophoresis on 10% SDS-PAGE polyacrylamide gel and transferred onto
PVDF blotting filters. PVDF membranes were incubated with villin or actin
antisera diluted 1 :500 and 1:5,000, respectively, and with antimouse and
antirabbit horseradish peroxidase conjugates, respectively (both diluted
1 :1 0,000). Detection of the immune complex was performed by autora-
diography. This is a representative experiment of three independent cx-
periments. (B) DDPIV activity in either proliferating (17.4 ± 3.5 mU/mg
protein) or differentiated (172.2 ± 20.7 mU/mg protein) CaCo-2 cells.
Specific enzyme activities are expressed as mU/mg of protein. One unit is
defined as the activity that hydrolyzes 1 tmol of substrate/mm at 37#{176}C.
Data are means (bars, SD) representing duplicate assays of three mdc-
pendent experiments.
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actin-binding protein, plays an important role in the mainte-
peroxide anion yielding peroxynitrite (ONOO ; Ref. 15),
which is transformed rapidly into nitrate at a physiological
pH. It can also control the synthesis of the highly reactive ‘OH
radical, arising from the interaction between H2O2 and fer-
rous complexes (Fenton reaction), by either chelating ferrous
ions (1 6) or increasing iron release (7).
bcl-2 may also regulate cell differentiation by modulating
the redox state of the cell. bcl-2 has been most studied as an
antiapoptotic protein (1 7, 1 8), but it is also a key modulator
of intracellular levels of oxygen species and has been shown
to decrease lipid peroxidation (1 9). The biochemical mech-
anism of the antioxidant activity of bcl-2 remains to be de-
termined, although the hypothesis has emerged that the
localization of bcl-2 to the membranes of mitochondria, en-
doplasmic reticulum, and nucleus near the sites of superox-
ide generation allows a direct interaction between bcl-2 and
#{176}2 ‘ leading to the removal of oxygen radicals.
GSTa is also an important component of cellular oxidant
defenses (20). Its expression is redox regulated and seems to
be correlated with the production of oxygen radicals (21 , 22).
GSTa reduces the concentration of fatty acid hydroperox-
ides (20), but in contrast to glutathione peroxidase, it cannot
metabolize H202. Therefore, it may intervene at a second
step to rescue the cell from lipid peroxidation-induced dam-
ages.
MTs are cysteine-rich, metal-binding proteins that are in-
volved in cell protection against toxic metals (23). In addition,
MTs inhibit the degradation of DNA by hydroxyl radicals (24),
and an inhibition of MT expression has been shown to in-
crease the cell sensitivity to oxidative injury (25). Indeed, MT
expression is associated with oxidative stress (26, 27) and
increases in the presence of an elevated level of free radicals
produced during hypoxia (26), or in response to H202 (27).
Using Western and Northern blot experiments and enzy-
matic assays, we studied the variation of the expression of
“sensor” oxidant proteins during CaCo-2 cell differentiation.
In this report, we demonstrated that the genes encoding
iNOS and bcl-2 were specifically switched off during the
enterocytic differentiation, whereas the expression of GSTa
and MT genes were increased. This indicated that different
redox-sensitive proteins were requisitioned depending on
the proliferation or differentiation status of the cell, and that
they might be linked to the oxygen radical production.
Results
CaCo-2: A Model of Intestinal Enterocytic Differentiation.
CaCo-2 cells differentiate spontaneously to enterocyte-like
cells when they are cultured for 20 days after confluency.
This means that they form polarized monolayers sealed by
tight junctions and display a well-developed apical brush
border membrane expressing specific hydrolases (28). Also,
CaCo-2 cells exhibit enzymatic and structural features that
have been detected in intestinal epithelial cells that migrate
from crypts to villi. We have studied two differentiation mark-
ers, the expression of which is associated with the brush
border. The serine protease DDPIV is involved in the hydrol-
ysis of X-pro-containing peptides and participates in the final
step of the intestinal peptide reabsorption (29). Villin, an
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nance of the brush-border cytoskeleton integrity (30). Using
enzymatic assay and immunoblotting experiments, we ob-
served that the expression of villin and DDPIV was 4.5- and
1 0-fold higher, respectively, in differentiated cells as com-
pared to growing cells (Fig. 1 , A and B, respectively), and
these increases were similar to previously published data
(28, 29).
Modulation of INOS Gene Expression during CaCo-2
Cell Differentiation. We have quantified the NOS activity in
CaCo-2 cells cultured 7 (growing cells) or 20 days (differen-
tiated monolayer) by carrying out Western and Northern blot
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Fig. 2. Modulation of iNOS protein expression depending on CaCo-2
cell differentiation. Cell extracts were homogenized in a 50 m HEPES
buffer and centrifuged as described in “Materials and Methods.” The
51 00,000 x g cytosolic fraction (2.5-mg cell extracts) from differently
aged CaCo-2 cells were purified on a 2’-5’-ADP Sepharose column,
precipitated with acetone, and mixed with Laernmli buffer. The samples
were subjected to SDS-PAGE (7.5%), and proteins were transferred on
PVDF membranes. Membranes were incubated with monoclonal antibod-
ies directed against murine iNOS (dilution, 1:500) or with polyclonal anti-
sera raised toward human iNOS (dilution, 1:100 for antibod? (Santa Cruz
Biotechnology), and dilution 1 :40,000 for antibody (gift of Dr. Mumford,
Merck Research Laboratories), and then with antimouse or antirabbit
horseradish peroxidase conjugates (diluted 1 :10,000). The immune corn-
plexes were revealed by autoradiography. Cell extracts from cytokine-
induced mouse macrophages were used as a positive control (1); purified
cytosolic extracts from CaCo-2 cells aged 7 days (2) or 21 days (3). These
are representative experiments of three performed independently.
analysis, radioenzymatic assays, and determination of NO
metabolites in the conditioned medium. To assess the spec-
ificity of the signal obtained in the Western blot analysis, we
used three antibodies, one raised toward rodent iNOS but
recognizing also the corresponding human protein, and two
directed against the human iNOS cells, which do not cross-
react with the murine iNOS isoform. The iNOS protein is
detected at Mr 130,000, indicating that this enzyme is con-
stitutively expressed by proliferating cells (Fig. 2). However,
the signal disappears in differentiated cells, showing that a
reduction in iNOS expression is correlated with the differen-
tiation status of the CaCo-2 cell line. This observation was
confirmed by radioenzymatic assays, which measured the
conversion of [H]L-arginine into [H]L-citruIline. Lysates from
proliferating cells were found to metabolize L-arginine at the
rate of 8.7 ± 6.0 pmol citrulline formed/mm . mg protein,
whereas in cells cultured 20 days, this metabolic pathway
was undetectable (Table 1). The activity found in growing
cells corresponds to that described for other human colon
cell lines (1 0, 1 1). In parallel, the amount of NO was quantified
as the accumulation of NO2 and NO3 in the medium.
Proliferating CaCo-2 cells had levels 2-fold higher (P <
0.001) as compared to that measured for the differentiated
cells (Table 1). In addition, the iNOS mRNA detected as a
4.4-kb transcript was 3-fold down-expressed in differenti-
ated cells versus proliferating cells (Fig. 3), supporting the
hypothesis that the iNOS gene may be regulated at the
transcriptional level in CaCo-2 cells. To investigate whether
the NO decrease corresponded to a similar variation in the
NO-dependent sGC activity, we performed measures of
cGMP in differently aged CaCo-2 cells in the presence or
absence of 5 /.tM DEA’NO (31), a well-described NO donor.
Table 1 Specific iNOS activity and measures of NO metabolite levels
during CaCo-2 cell differentiation
The conversion of L-argmnmne into L-citrulline and the determination of
nitrites and nitrates were performed as descnbed in methods. Results are
expressed as: pmoles of citrulline formed/mm . mg protein, mean ± SD
(n = 3). nanomoles N02/48 h/mg protein, mean ± SD (n = 3).
Proliferating Differentiated
cells cells
Specific activity 8.7 ± 6.0 ND#{176}
(pmol citrulline formed!
mm . mg protein)
NO and NO3 levels 8.7 ± 2.0 3.6 ± 03b
(nmol NO/mg
protein)
a ND, not detectable.
b p < 0.001 (differentiated versus proliferating cells).
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Fig. 3. iNOS mRNA expression in differentiated (1) and proliferating (2)
CaCo-2 cells. RNA was extracted from differentiated or proliferating cell
cultures, and 10 Lg were loaded onto agarose gel and transferred. The
membrane was then probed with the 4.1 -kb human iNOS cDNA as do-
scribed in “Materials and Methods.” A, Northern blot analysis of iNOS
mRNA. RNA was extracted from differentiated and proliferating CaCo-2
cells. B, ethidium bromide staining agarose gel. The 285 and 185 RNA are
shown to account for loading.
Table 2 shows that the basal cGMP level in growing cells was
very low but increased significantly (P < 0.05) after DEAJNO
induced stimulation of sGC. In contrast, exposure of differ-
entiated cells to DEA/NO did not increase cGMP levels,
consistent with a loss of NO-dependent sGC activity. The
higher amount of cGMP produced in differentiated cells in
the absence of DENNO and detectable iNOS activity might
be due to an increase in the particulate guanylate cyclase
Table 2 Variation in the cGMP levels during CaCo-2 cell
differentiation: NO-dependent activation of the sGC in differently
aged cells. CaCo-2 cells aged 5 or 21 days were incubated with
5 j.M DEA/NO and 0.5 mM isobutylrnethylxanthine. cGMP level was
determined by AlA. Values (fmol cGMP/rng protein) are expressed as
means ± SD (n = 4).
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Fig. 4. p53 expression and NFKB activity in proliferating and differenti-
ated CaCo-2 cells. A, Western blot analysis of p53 during CaCo-2 cell
differentiation. Five hundred g of CaCo-2 cell extracts from either pro-
liferating (1) or differentiated (2) cells were homogenized in HEPES buffer
as described in “Materials and Methods,” loaded onto a 10% polyacryl-
arnide gel, and transferred. Blotted membranes were incubated with p53
or actin antisera diluted 1 :1 0,000 and 1 :5,000, respectively, and then with
antirabbit horseradish peroxidase conjugate diluted 1 :10,000. Eighty g
of Beas-2B cell extracts were loaded in parallel as a positive control. B,
NFKB-dependent luciferase activity during CaCo-2 cell differentiation.
NFKB3-luc transfected cells from day 7 (1) or day 21 (2) were exposed to
200 n PMA for 8 h, and cell extracts were collected in lysis buffer.
Luciferase activity was determined, normalized to protein content, and
expressed as an arbitrary unit. Values for proliferating cells cultured in the
absence or in the presence of PMA correspond to 3.84 ± 1 .66 and 8.27 ±
0.65, respectively. Values for differentiated cells cultured in the absence or
in the presence of PMA correspond to 1 .67 ± 0.90 and 7.61 ± 1.24,
respectively. Data are expressed as means ± SD. **P < 0.01 unstimu-
lated differentiated versus unstimulated proliferating cells. Statistical corn-
parisons were performed using the Student’s paired t test.
1 2
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Proliferating
cells
Differentiated
cells
Unstimulated 3.89 ± 6.3 31.1 ± 4.2
DEAJNO 17.53 ± 12.3e 32.2 ± 5.1ap < 0.05 DEA/NO (tre ated versus control prolif crating cells).
activity, which is known to be expressed in CaCo-2 mono-
layers (32). To identify the component(s) implicated in the
decline of iNOS expression, we analyzed the expression of
the suppressor gene p53, which down-regulates iNOS (33),
and that of NFKB, which induces iNOS in rodent and human
cells (34, 35). Western blot analysis indicated that the p53
level is identical in proliferating and differentiated cells (Fig.
4A). To determine the level of NFKB activation, CaCo-2 cells
were stably transfected with NFKB-binding sites linked to the
luciferase reporter gene and were cultured for either 7 or 21
days. As presented in Fig. 4B, a 2-fold diminution (P < 0.01)
in the basal luciferase activity was observed in the differen-
tiated cells, corroborating the fact that a decrease of NFxB
basal activity is associated with the decline of iNOS expres-
sion. As a control, the transfected cells were incubated in the
presence of PMA, an inducer of protein kinase C well known
to activate NFxB. Total luciferase activity was similar when
proliferating and differentiated cells were treated by PMA,
showing that the basal NFKB activity, but not the NFKB
protein level, decreases during differentiation.
Enhanced Expression of GSTa and MT and Decreased
Level of bcl-2 during the CaCo-2 Cell Differentiation. The
presence of GSTa, MT, and bcl-2 was characterized in crude
extracts of proliferating and differentiated CaCo-2 cells using
Western blot analysis. As shown in Fig. 5, the proteins GSTa,
MT, and bcl-2 were detected as single bands at M, 27,000,
8,000, and 25,000, respectively. The expression of GSTa and
MT was higher in the older cells (a 4-fold increase was
measured for the GSTa protein), whereas that of bcl-2 was
3-fold lower. This indicates that the regulation of antioxidant
proteins depends on the status of enterocytic cell differen-
tiation.
Discussion
The sustained level of radical production detected in human
colon tumor cells (3, 4) suggests that oxidant stress pro-
motes tumor cell proliferation. However, this implies the ex-
istence of a critical balance between the production of H2O2
and the level of specific antioxidant defenses to prevent DNA
damage and lipid peroxidation induced by free radicals. We
were interested to know whether a modification in the growth
of cancer cells would be associated with altered expression
of redox-sensitive proteins. To this end, we analyzed the
expression of pro- and antioxidant capacities of intestinal
CaCo-2 cells during their enterocyte-like differentiation.
This report shows for the first time that the expression of
NOS changes during the intestinal cell differentiation, being
Panel A
I Iii
- -

E
#{182}1
higher in proliferating cells and lower in postconfluent cells,
which have stopped growing. The parallel diminution of the
NOS mRNA raises the possibility that this biological process
may include a decrease in the iNOS transcriptional level. The
p53 protein, which can down-regulate iNOS transcription
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Fig. 5. Western blot analysis of bcl-2, GSTa, and MT in differently aged
CaCo-2 cells. Fifty g of proliferating (1) or differentiated (2) cell extracts
were loaded onto 10% SDS-PAGE polyacrylarnide gel(forthe detection of
bcl-2 and GSTa) or onto 15% SDS-PAGE polyacrylarnide gel (for the
detection of Ml) and transferred onto PVDF membranes. Blotted rnern-
branes were incubated with antisera directed against hurnan bcl-2 and
GSTa diluted 1 :40 and 1:2,000, respectively, and MT antibody was diluted
1 :1 00. Antirnouse horseradish peroxidase lgG was used for the detection
of bcl-2 and antirabbit horseradish peroxidase conjugates for the revela-
tion of GSTr, MT and actin. Both conjugates were diluted 1 :10,000. This
is a representative experirnent of two perforrned independently.
(33), seems not to be involved in this event, given that its
expression level did not change during differentiation. But we
cannot totally exclude a regulatory effect of p53, because
this protein is mutated in CaCo-2 cells2, and it is not known
whether this mutation changes the DNA-binding ability of
p53. On the other side, the concomitant decrease of the
basal NFKB activation argues for a role of NFxB in the reg-
ulation of iNOS activity in the CaCo-2 cells, as has been
found in other human cells (1 1 , 35). One might also speculate
that the substrate itself, L-arginine, controls iNOS transcrip-
tion, because the L-arginine y transport is also lower in
differentiated CaCo-2 cells (36). Supporting this idea is the
observation that the other L-arginine metabolic pathway con-
stituted by the ornithine decarboxylase enzyme decreases in
older CaCo-2 cells (37).
What is the biological significance of the progressive de-
dine in NO production during the cell differentiation? Several
reports provide evidence that low but persistent levels of NO
are associated with tumor progression. Jenkins et a!. (38)
observed that the injection of nude mice with the iNOS-
transfected DLD-1 human colon cell line resulted in tumors
with a higher growth rate and vascularization, compared to
tumors formed by the parental cell line. NOS activity in
human breast cancer was found to be directly correlated with
the state of the malignancy (39). Taken together, these ob-
servations emphasize the potential roles of NO in tumor
growth. One of the mechanisms by which low-level NO syn-
thesis elicits biological effects is through the activation of
sGC (5), for the production of cGMP. Our data demonstrate
the presence of NO-activated sGC in intestinal cells in re-
sponse to exogenous NO and show that the diminution of
iNOS expression is associated with a reduced activity of sGC
in differentiated CaCo-2 cells. cGMP has been associated
with growth-inhibitory effects on vascular smooth muscle
cells (40), but whether cGMP has similar function in the
epithelia is not known. Although NO-induced sGC stimula-
tion has already been observed in bronchial epithelial cells
(31), no correlation was found between cGMP synthesis and
cell proliferation. NO controls iron availability (7), and this
regulatory effect may constitute a physiological mechanism
in the modulation of CaCo-2 cell proliferation, because iron
starvation has been shown to limit cell replication (6). Iron
release also involves targets sensitive to low NO concentra-
tions (7, 41) corresponding to the level of iNOS-specific
activity detected in growing CaCo-2 cells. Although we did
not measure the intracellular iron concentration in differently
aged CaCo-2 cells, this NO-regulated pathway is functional
in CaCo-2 cells as demonstrated by Sanchez et a!. (41), who
observed an increase in iron absorption in CaCo-2 cells
treated with 10 j.LM of the NO donor S-nitroso-N-acetylpeni-
cillamine. Finally, NO might promote the tumor cell growth by
preventing the cell death due to the deleterious effects of the
other oxidants present in significant levels in human tumor
cell lines (3, 4). Indeed, NO counteracts the toxicity mediated
by the superoxide anion, hydrogen peroxide, and alkyl hy-
droperoxides (1 5, 16), and the mechanism of this effect has
been proposed to be the scavenging of either #{176}2 (1 5) or
ferrous complexes (16) inhibiting the formation of the highly
toxic radicals H202 and ‘OH. In the intestine, low levels of NO
have been shown to decrease injury triggered by lipopo-
lysaccharide and H202 (42). Whether NO maintains a pro-
oxidant state thought to promote growth responses (1) and
mutagenesis (2), or functions as an antioxidant that abates
the radical-mediated apoptosis of cancer cells and increases
their survival is unknown. Our data show a decline in iNOS
expression during the CaCo-2 cell differentiation, suggesting
but not proving a role for NO in cell growth responses.
Concurrent with the decline in iNOS expression, bcl-2
levels decreased in the differentiated cells. A gradient of
bcl-2 expression has already been described along the
crypt-villus axis of the intestinal epithelium (1 7). The intense
rate of cell proliferation in the crypt is accompanied by the
generation of oxygen compounds. Therefore, high levels of
bcl-2 could play a role in the survival of intestinal stem cells
and perhaps in cancer cells that constitutively produce rad-
icals. The coexpression of bcl-2 and 1NOS genes in prolifer-
ating CaCo-2 cells supports the hypothesis that they both
act to inhibitthe damage induced by oxygen species, thus
facilitating tumor growth. Furthermore, NOS and bcl-2 ex-
pression could be related; i.e., NO may control the expres-
sion of bcl-2, as already observed in lymphocytes (43).
By contrast, the expression of GSTa was induced 4-fold
during CaCo-2 cell differentiation. Similar results were re-
ported by Zucco et a!. (44), who demonstrated that glutathi-
one peroxidase selenium-independent activity increases in
CaCo-2 cells between 7 and 21 days of culture. The GSTa
expression is controlled by antioxidant response elements
consisting of activator protein 1 -like binding sites in the
5’-flanking region of the GST Ya gene (21 , 22). In the differ-
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5 P. Shaw, personal communication.
entiated human HepG2 cell line, the activator protein 1 -me-
diated transcription of GSTa is induced by the production of
‘OH radicals (22). Therefore, it is likely that the GSTa expres-
sion is also redox-regulated during CaCo-2 cell differentia-
tion. The redox induction of GSTa constitutes a part of the
cell responses to oxidative stress and may be triggered by
the emergence of novel radical oxygen species.
Similar to the GSTa, the MT expression, although unde-
tectable in proliferating cells, was largely induced in post-
confluent CaCo-2 cells. The presence of a hypoxia-respon-
sive element in the human MT-Il gene (26) and that of H2O2-
inducible antioxidant response element in the mouse MT-i
promoter (27) have been reported. However, the regulation of
human MT expression is not really understood. it appears
that the function (45, 46) and the regulation (26, 27) of MT are
associated closely with the cell oxidative stress. MT protein
is able to prevent the hydroxyl-mediated DNA fragmentation
(24) and to inhibit the cell membrane peroxidation (45), al-
though the mechanism of these actions is not clear. The
presence of thiolate clusters and Zn2 elements in MT pro-
teins, which together act against lipid peroxidation, has been
thought to account for the protective function of MT during
cell injury (45, 46).
In conclusion, the present data showed a shift in specific
“sensor” oxidant genes during the CaCo-2 cell differentia-
tion. The level of iNOS and bcl-2 proteins were higher in
proliferating cells, whereas in differentiated cells, these pro-
teins were replaced by an enhanced expression of GSTa
enzymes and MTs. These substitutions display an adaptive
response of the cell and may be linked to the redox potential,
which is then a critical determinant in cell proliferation, dif-
ferentiation, and apoptosis.
Materials and Methods
Antibodies. Antibodies against mouse iNOS were purchased from
Transduction Laboratories (Affiniti, Nottingham, England). Human iNOS
antiserum4 was obtained from Dr. A. G. Glaser(Santa Cruz Biotechnology,
Basel, Switzerland), and antibody was a kind gift of Dr. R. A. Mumford
(Merck Research Laboratories, Rahway, NJ). Antibodies directed against
human bcl-2 and p53 were obtained from Oncogene Science (Basel,
Switzerland) and Signet Laboratories (Alexis Corp., Laufelfringen, Swit-
zeriand), respectively. Rabbit polyclonal antisera against human GSTa
(47, 48) and a-actin are generous gifts from Dr. H. Mukhtar (University
Hospitals of Cleveland, Cleveland, OH) and Dr. Y. C. Awasthi (University
of Texas Medical Branch, Galveston, TX), and from Dr. G. Gabbiani
(Department of Pathology, Geneva University, Geneva, Switzerland), re-
spectively. Polyclonal MT antibodies have been developed in our labora-
tory (23). Antirabbit and antimouse horseradish peroxidase conjugates
were obtained from Amersharn (Zurich, Switzerland) and Bio-Rad (Glatt-
brugg, Switzerland), respectively. Protein concentration was determined
by the bicinchonic acid reagent (Pierce Chemical Co., Rockford, IL), using
bovine serum albumin as a standard.
Cell Culture. CaCo-2 clone 1 cells(29) were isolated from the parental
human colon adenocarcinoma CaCo-2 cell line (28) and were cultured
during 20 passages(passages 50-70) under9% CO2 atmosphere at 37#{176}C
in DMEM (Hyclone, Integra Biosciences IBI, Wallisellen, Switzeriand) sup-
plemented with 10% (v/v) heat-inactivated (55#{176}Cfor 30 mm) fetal bovine
serum (Life Technologies, Inc., Basel, Switzerland), 2 mi L-glutamine
(Integra Biosciences), 1 % nonessential amino acids (Seromed, Fakola,
Basel, Switzerland), and 100 pg/mI of penicillin and streptomycmn (Ufe
Technologies. Inc.). CaCo-2 cells were shown to be mycoplasma-free
using a mycoplasma detection kit (Bcehringer Mannheim, Rotkreuz, Swit-
zerland). Culture medium was changed every 2 days. In vitro, cells differ-
entiate after 3 weeks postconfluency, and this biological process can be
quantified by an increased synthesis of villin and DDPIV (Fig. 1).
Measurement of DDPIVACtIVItY. Cells(106)were seeded in a 10-cm2
culture dish and cultured for 7 or 21 days. Cells were rinsed and collected
in 500 l of ice-cold PBS with a rubber policeman. After rapid sonication
at 4#{176}C,40 pJ of the whole-cell homogenate (diluted 1 :10) was incubated
in a solution containing 120 .d of 0.01 mri Tris buffer (pH 7.6) and 40 .d of
1 .4 mg/mI of the substrate H-gly-pro-p-nitroanilide (BACHEM, Inc.,
Bubendorf, Switzerland). The absorbance of the hydrolyzed substrate was
measured every 5 mm for 30 mm at 405 nm using a microtiter plate reader
(ELX8O8, Bio-Tek Instruments, Inc., Wilrijk, Belgium). Specific enzyme
activities are expressed as mU/mg of protein. One unit is defined as the
activity that hydrolyzes 1 mol of substrate/mm at 37#{176}C.Mean ± SD
represents duplicate assays of three independent experiments.
Measurement of N02/N03. Total nitrite was quantified using the
Griess reagent after reduction of nitrate into nitrite as adapted from
Pollock et al. (49). Briefly, 105_106 cells were seeded in a 12-well culture
dish and cultured for 5 or 21 days. The culture medium was replaced 48 h
before the collection of the supernatants, which were centrifuged for 5 mm
at 5000 rpm to remove particles. Samples were incubated for 15 mm at
37#{176}Cwith 40 .LM NADPH (Fluka, Buchs, Switzerland), 1 ui flavine adenine
dinucleotide (Sigma Chemical Co., Buchs, Switzerland), and 0.2 units/mI
of nitrate reductase (Boehringer Mannheim). One m sulfanilamide rca-
gent (Sigma Chemical Co.), 1.4 N HCI, and 1 m N-(1-naphthyl)ethyl-
enediarnine (Sigma Chemical Co.) were added sequentially to the incu-
bation. NO2 concentration was determined by the change in absorbance
at 540 nm, which was compared to a standard curve of NaNO2 diluted in
DMEM. The recovery of N03 was 95%. Results are expressed as nmol
of N02/mg protein, and are the mean ± SD of duplicate determinations
of three separate experiments.
Transfection. The NF,cB3-luc plasmid containing three NF.cB consen-
sus sequences cloned in front of the luciferase gene reporter was pro-
vided kindly by Dr. B. Sugden (McArdle Laboratory, Madison, WI; Ref. 50).
CaCo-2 cells were transfected with a DNA mixture containing 6 .tg
NFB3-Iuc vector and 600 ng hygromycmn expression vector, using Upo-
fectin (Life Technologies, Inc.) according to the manufacturer recommen-
dations. Forty-eight h after transfection, cells were trypsinized and cul-
tured in the presence of 180 pg/mI hygromycmn (Boehringer Mannheim)
until a stable NF.cB3-Iuc-transfected population was established. The
transfected cells were seeded in a 1 2-well culture dish at a density of 1 o
cells/well and cultured either 7 or 21 days. Two wells per condition were
then exposed to 200 nM PMA(Sigma Chemical Co.)for8 h. Afterthis time,
cell extracts were collected in either 200 l of 1 x lysis buffer [1 .25 m Tris
(pH 7.8) with H3PO4, 10 mM CDTA, 10 mi DTT, 50% glycerol, and 5%
Triton X-100] for the 7-day-old cells, or in 500 I of 1 x lysis buffer for the
21 -day-old cells. Luciferase assays were carried out according to the
manufacturer instructions (Promega, Catalys SA, Wallisellen, Switzeriand)
using a luminometer (LKB Wallac, Lucerne, Switzerland). The values rep-
resent the mean ± SD of triplicate assays of two independent experi-
ments.
Preparation of Cellular Extracts. For the detection of villin, bcl-2,
MT, GSTa, and iNOS proteins, cells were collected in PBS and centri-
fuged for 5 mm at 5000 rpm. The pellet was homogenized in a 50 mri
HEPES buffer (pH 7.4) containing 10% glycerol, 100  DTT (Fluka), 5
sg/ml leupeptmn (Sigma Chemical Co.), 1 g/ml antipain (Sigma Chemical
Co.), 1 g/ml pepstatin (Sigma Chemical Co.), 5 g/ml aprotinin (Sigma
Chemical Co.), 1 mM sodium vanadate (Merck, Basel, Switzerland) and
200  phenylmethylsulfonyl fluoride (Boehringer Mannheim). After three
freezing/thawing cycles, the homogenate was centrifuged at 4#{176}Cfor 30
mm at 1 00,000 x g, and the supernatant was collected. For the detection
of p53, cells were scraped in 40 mri HEPES buffer(pH 7.2) containing 100
mM NaCI, 20% glycerol, 1 mri DTT, 1 m EDTA(Fluka), 0.5% NP4O(Fluka),
and 2 m.i phenylmethyisulfonylfluoride. The homogenate was centrifuged
(75,000 rpm at 4#{176}Cfor 15 mm), and the supematant was collected.
iNOS Purification. iNOS purification was carried out using a modifi-
cation of a previously described protocol(51) and was set up using EC219
rat endothelial cells stimulated with IFN-’y and Iipopolysaccharide (52).
The 5100,000 x g cytosolic fractions (2.5-mg proteins) were loaded on
chromatography columns containing 2-5’ ADP Sepharose 4B gel (Phar-
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macia AG, Dubendorf, Switzeriand), which had been equilibrated with a
buffer A containing 10 mM K2HPO4 (pH 7.4), 100 rn NaCI, 10% glycerol,
0.5 mM L-arginine, 1  BH4 (Alexis Corp.), and 3 m DTT. The columns
werewashed with buffer A containing 300 m NaCI and then rinsed with
a buffer B [10 mM K2HPO4 (pH 7.4), 100 mu NaCI, 0.5 mti L-arginine, 1 w
BH4, and 3 mM DTF]. iNOS was eluted with buffer B, containing 10 m
NADPH and 0.5 iii instead of I BH4. The NADPH-eluted fractions
were then precipitated with 5 volumes of acetone and dried, and the
pellets were homogenized in Laemmli buffer. The yield based on chro-
matography was40%.
SDS-PAGE and Western Blot Analysis. Fifty ig of protein (for the
detection of bcl-2, villin, actin, and GSTa) or 500 g of protein (for the
detection of p53) were mixed with Laemmli buffer and were loaded on
10% SDS-PAGE polyacrylamide gel (53). For the detection of MT. 50 .&g
of protein were mixed with a buffer consisting of 300 mi sucrose, 0.35%
SDS, and 0.6 mM CdCl2, and loaded on 15% SDS-PAGE polyacrylamide
gel (23). The iNOS samples were loaded on 7.5% SDS-PAGE polyacryl-
amide gel. The separated proteins were transferred onto nylon filters
(Dupont Dc Nernours, Regensdorf, Switzeriand), according the procedure
of Towbin et a!. (54). Blotted membranes were incubated 2 h In the
presence of washing buffer [150 m NaCI, 10 m Tris-HCI (pH 8), and
0.05% Tween 20] containing appropriate antisera. Antibodies raised
against mouse iNOS were diluted 1 :500, and those directed against
human iNOS were used at a dilution of 1 :100 (for Santa Cruz Biotechnol-
ogy antibodies) or 1 :40,000 (for antibodies from Dr. R. A. Mumford),
respectively. Antibodies directed against human bcl-2, villin (30), GSTa
(47, 48), p53, and MT(23) were diluted 1:40, 1 :500, 1:2,000, 1:10,000, and
1:100, respectively. Human actin antiserum diluted 1:5,000 was used as
an internal loading control. For the detection of p53, cell extracts from
Beas-2B cells (a nontumorigenic human bronchial epithelial cell line; Ref.
55) were used as positive controls. After four washes, filters were incu-
bated for 1 h in washing buffer containing either antirabbit or antimouse
horseradish peroxidase conjugates diluted 1:10,000. Detection of the
immune complex was performed using the luminol enhancer solution
supersignal TM CL-horseradish peroxidase (Pierce, Lausanne, Switzer-
land). Cell extracts from cytokine-mnduced mouse macrophages (Affiniti)
were used as a positive control. Induction factors weremeasured using a
scanning densitometer (2202 Ultrascan, LKB Bromma). Three expel-
ments were performed and results are from one representative expel-
ment.
INOS ActIvIty Assay. The iNOS activity assay wasperformed as re-
ported previously (31) using a cation-exchange column to separate ra-
diolabeled citrulline from argmnmne. Briefly, 100 .&l of cell homogenate were
mixed with 150,000 cpm L-[’H]arginine(59 CVmmoI; Amersham Corp.), 50
 arginine, 2 mM NADPH, 5  flavine adenine dinucleotide, 5 pi BH4,
and 1 mi EGTA, and incubated for 30 mm at 37#{176}Cin the presence or in
the absence of NG.methyi.Largmnine (Alexis Corp.) to determine the ape-
cific L-arginine metabolism due to iNOS. The incubation was applied to a
Dowex AG 5OWX-8 (Bio-Rad, Richmond, CA) resin column and
L-(H]cftrulline was eluted with cold L-citrulline and measured by scintil-
lation counting. The results were expressed as specific activities, pmol of
citrulline formed/mm . mg protein. Mean ± SD (n = 3) represents three
measures performed separately.
Determination of CGMP Concentration. CaCo-2 cells were seeded
In a 12-well culture dish at a density of 10 cells/well. They were grown
either 5 or 21 days and incubated 10 mm with 5  of the NO donor
DEA/NO(Ref. 31 ; agenerous giftfrom L Keefer, National Cancer Institute,
Frederick, MD), in the presence of 0.5 m isobutylmethylxanthmne (Cal-
biochem, Lucerne, Switzerland). Thesupematant wasthen withdrawn and
the cells were lysed with 500 l of cold ethanol containing HCI 10 mti and
frozen at -70#{176}C.After evaporation under vacuum, the pellet was recon-
stituted in 250 l of 50 mM sodium acetate buffer (pH 4), acetylated for 10
mm with acetic anhydride/triethylamine (2:1 , 5 pJ per 100 d buffer), and
the cGMP determination was made by RIA using anti-cGMP antibodies
from Meloy Laboratories (Springfield, VA). The sensitivity of the RIA is 1
frnol of CGMP. Results represent the mean ± SD (n = 4).
Northern Blot Analysis. Extraction of RNA using guanidmnium thiocy-
anate and Northern blot analysis were performed as already described
(31) using the human hepatocyte iNOS cDNA (56). Levels of iNOS RNA
wee measured by scanning and directly compared, because the RNA
loading indicated by the rRNAs 183 and 285 onto the agarose gel was
identical. The results are representative of two independent experiments.
StatIstical Analysis. Data represent means ± SD and were compared
using the Student’s t test. A probability value <0.05 was considered a
significant difference.
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